Annual Meeting and Educational Conference
SEPTEMBER 24-26, 2018
WASHINGTON, DC
 
  • > AGENDA
  • > FACULTY
  • > HOME INFUSION PRE-CONFERENCE WORKSHOP
  • > CSP PREP COURSE
  • > ABSTRACTS
  • > CONTINUING EDUCATION
  • > WOMEN IN SPECIALTY PHARMACY
  • > NASP MEMBER
  • > GENERAL (NON-MEMBER)
  • > NASP STUDENT
  • > GENERAL STUDENT
    (NON-MEMBER)
  • > PHARMACY TECHNICIANS
  • > ADD-ON REGISTRATION
  • CE Satellite Symposia

    Maryland Room • Located on the Lobby Level of Marriott Wardman Park

    Tuesday, September 25, 2018 • 11:30 am – 1:00 pm – Lunch Session
    Title: Pulmonary Arterial Hypertension: Individualized Treatment Strategies
    Sponsor: ProCE, Inc. and the Center for Specialty Pharmacy Education (CSPE)
    Description: New treatment paradigms have emerged as the number and types of pharmacotherapy for pulmonary arterial hypertension (PAH) continue to increase. Despite the improved understanding of the pathobiology of PAH, and the availability of guidelines for risk stratification, PAH continues to be misidentified and underdiagnosed. The options for monotherapy, drug combinations, and sequential treatment can be used to tailor therapy for patients with PAH and improve outcomes. This symposium will provide pharmacists and nurses with an improved knowledge of PAH, including a review of pathophysiology, disease subcategories, diagnosis, treatment guidelines, approved therapies, disease progression, and disease monitoring recommendations. The role of the specialty pharmacy team in optimizing outcomes will be discussed and explored. Discussions will emphasize collaborative care and the importance of interprofessional communication, particularly between outpatient and inpatient teams. Strategies for effective patient‒caregiver communication will also be discussed and presented through the use of case studies.
    Supporter: This CE activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc. and AllianceRx Walgreens Prime.

    For more information, go to http://www.ProCE.com/activities/activity_detail?id=793.

    Wednesday, September 26, 2018 • 7:00 am – 8:00 am – Breakfast Session
    Title: Diminishing Unintentional Exposure to Chemotherapeutic Drugs with Novel Technology and Ready to Administer (RTA) Drug Delivery
    Sponsor: Pharmacy Times Continuing Education
    Description: Due to increasing concern about the risk and exposure of health care workers who handle, prepare, or administer hazardous drugs (HDs), such as chemotherapeutic agents. Given the potential health risks associated with unintentional exposure to these agents, this program will highlight ways that specialty pharmacists can stay well informed on current best practices and appropriate measures for the safe handling of chemotherapeutic agents, including recent technological advances in drug delivery, such as ready to administer (RTA) forms.
    Supporter: This activity is supported by an educational grant from Sun Pharmaceutical Industries, Inc.

    For more information, go to www.pharmacytimes.org/live/nasp-safe-handling.

    Wednesday, September 26, 2018 • 12:00 pm – 1:15 pm – Lunch Session
    Title: The Role of Biologics and Biosimilars in the Management of Rheumatoid Arthritis: Considerations for the Specialty Pharmacist
    Sponsor: Pharmacy Times Continuing Education
    Description: This educational session will inform specialty pharmacists on the appropriate treatment targets for patients with rheumatoid arthritis (RA) and how to evaluate different biologic DMARDs for patients in whom anti-TNFα treatment has failed. This program will highlight the biosimilar landscape, its impact on RA management, and how to utilize these therapies to enhance the quality of life and care of patientswith RA.
    Supporter: This activity is supported by an educational grant from Pfizer.

    For more information, go to www.pharmacytimes.org/live/nasp-ra.

    For registration assistance, please email info@naspmeeting.com, or call +1 (888) 949-2964 between 9:00 am and 5:00 pm US EDT.
    Early Bird Registration ends Friday, June 1, 2018 at 6:00pm EDT